3,085
Views
7
CrossRef citations to date
0
Altmetric
Articles

Clearance of HR-HPV within one year after focused ultrasound or loop electrosurgical excision procedure in patients with HSIL under 30

ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all
Pages 15-21 | Received 24 Aug 2021, Accepted 21 Nov 2021, Published online: 22 Dec 2021

References

  • Sahlgren H, Elfström KM, Lamin H, et al. Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program. Am J Obstet Gynecol. 2020;222(3):253.e1–253.e8.
  • Sand FL, Kjaer SK, Frederiksen K, et al. Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status. Int J Cancer. 2020;147(3):641–647.
  • Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ. 2002;325(7364):572.
  • Chan PK, Ho WC, Wong MC, et al. Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol. 2009;81(9):1635–1644.
  • Baandrup L, Munk C, Andersen KK, et al. HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3. Gynecol Oncol. 2012;124(2):281–285.
  • Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8):711–723.
  • Hildesheim A, Gonzalez P, Kreimer AR, et al. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol. 2016;215(2):212.e1–212.e15.
  • Castle PE, Schiffman M, Wheeler CM, et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113(1):18–25.
  • McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425–434.
  • McBride E, Marlow LAV, Forster AS, et al. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: the psychological impact of primary screening (PIPS) study. Int J Cancer. 2020;146(8):2113–2121.
  • McCaffery K, Waller J, Forrest S, et al. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG. 2004;111(12):1437–1443.
  • WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva (Switzerland): World Health Organization; 2021.
  • Wu J, Jia Y, Luo M, et al. Analysis of residual/recurrent disease and its risk factors after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia. Gynecol Obstet Invest. 2016;81(4):296–301.
  • Jiang Y, Chen C, Li L. Comparison of cold-knife conization versus loop electrosurgical excision for cervical adenocarcinoma in situ (ACIS): a systematic review and meta-analysis. PLoS One. 2017;12(1):e0170587.
  • Bogani G, DI Donato V, Sopracordevole F, et al. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser conization: a 5-year follow-up study. Gynecol Oncol. 2020;159(3):636–641.
  • Conner SN, Cahill AG, Tuuli MG, et al. Interval from loop electrosurgical excision procedure to pregnancy and pregnancy outcomes. Obstet Gynecol. 2013;122(6):1154–1159.
  • Li CZ, Wang ZB, Yang X, et al. Feasibility of focused ultrasound therapy for recurrent cervicitis with high-risk human papillomavirus infection. Ultrasound Obstet Gynecol. 2009;34(5):590–594.
  • Fu Z, Fan Y, Wu C, et al. Clinical efficacy and mechanism for focused ultrasound (FUS) in the management of cervical intraepithelial neoplasia 1 (CIN1). Int J Hyperthermia. 2020;37(1):339–345.
  • Wang W, Liu Y, Pu Y, et al. Effectiveness of focused ultrasound for high risk human papillomavirus infection-related cervical lesions. Int J Hyperthermia. 2021;38(2):96–102.
  • Hoffman SR, Le T, Lockhart A, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review. Int J Cancer. 2017;141(1):8–23.
  • Choi MC, Jung SG, Park H, et al. Photodynamic therapy for management of cervical intraepithelial neoplasia II and III in young patients and obstetric outcomes. Lasers Surg Med. 2013;45(9):564–572.
  • Zhao XL, Liu ZH, Zhao S, et al. Efficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in China. Int J Cancer. 2021;148(6):1419–1427.
  • Moore EE, Danielewski JA, Garland SM, et al. Clearance of human papillomavirus in women treated for cervical dysplasia. Obstet Gynecol. 2011;117(1):101–108.
  • Kreimer AR, Guido RS, Solomon D, et al. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiol Biomarkers Prev. 2006;15(5):908–914.
  • Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol. 2013;130(2):264–268.
  • Vintermyr OK, Iversen O, Thoresen S, et al. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway. Gynecol Oncol. 2014;133(2):159–166.
  • Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102(19):1478–1488.
  • Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015;136(2):178–182.
  • Ronco G, Dillner J, Elfström KM, et al. International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524–532.
  • Gosvig CF, Huusom LD, Deltour I, et al. Role of human papillomavirus testing and cytology in follow-up after conization. Acta Obstet Gynecol Scand. 2015;94(4):405–411.
  • Rabasa J, Bradbury M, Sanchez-Iglesias JL, et al. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study. BJOG. 2020;127(1):99–105.
  • Cuschieri K, Bhatia R, Cruickshank M, et al. HPV testing in the context of post-treatment follow up (test of cure). J Clin Virol. 2016;76(1):S56–S61.
  • Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and Meta-analysis. Lancet. 2006;367(9509):489–498.
  • Ciavattini A, Clemente N, Delli Carpini G, et al. Loop electrosurgical excision procedure and risk of miscarriage. Fertil Steril. 2015;103(4):1043–1048.
  • Frega A, Santomauro M, Sesti F, et al. Preterm birth after loop electrosurgical excision procedure (LEEP): how cone features and microbiota could influence the pregnancy outcome. Eur Rev Med Pharmacol Sci. 2018;22(20):7039–7044.
  • Santesso N, Mustafa RA, Wiercioch W, et al. Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2016;132(3):266–271.
  • Wijlemans JW, de Greef M, Schubert G, et al. A clinically feasible treatment protocol for magnetic resonance-guided high-intensity focused ultrasound ablation in the liver. Invest Radiol. 2015;50(1):24–31.
  • Li C, Xiong X, Li Y, et al. Therapeutic effects of focused ultrasound in 4014 patients with symptomatic cervical ectopy. Ultrasound Med Biol. 2013;39(4):604–610.